Harmony Biosciences Holdings, Inc. financial data

Symbol
HRMY on Nasdaq
Industry
Pharmaceutical Preparations
Location
630 W Germantown Pike, Suite 215, Plymouth Meeting, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 305 % -35%
Quick Ratio 3.8 % -23.4%
Debt-to-equity 62.7 % +1.9%
Return On Equity 23.2 % -30.4%
Return On Assets 14.2 % -30.9%
Operating Margin 25.7 % -30.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57M shares -2.63%
Common Stock, Shares, Outstanding 57M shares -2.63%
Entity Public Float 1.17B USD -13.6%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 56.9M shares -5%
Weighted Average Number of Shares Outstanding, Diluted 58.1M shares -4.25%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 682M USD +25.8%
Research and Development Expense 141M USD +153%
Selling and Marketing Expense 110M USD +20.3%
General and Administrative Expense 109M USD +21.4%
Operating Income (Loss) 175M USD -12.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 175M USD -1.39%
Income Tax Expense (Benefit) 52.7M USD +94.8%
Net Income (Loss) Attributable to Parent 123M USD -18.7%
Earnings Per Share, Basic 2.16 USD/shares -14.6%
Earnings Per Share, Diluted 2.12 USD/shares -13.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 387M USD +19.3%
Accounts Receivable, after Allowance for Credit Loss, Current 81.5M USD +21.2%
Inventory, Net 6.92M USD +35.9%
Other Assets, Current 7.46M USD +30.7%
Assets, Current 522M USD +12.8%
Deferred Income Tax Assets, Net 185M USD +84.1%
Property, Plant and Equipment, Net 750K USD +75.2%
Operating Lease, Right-of-Use Asset 2.32M USD -5.54%
Intangible Assets, Net (Excluding Goodwill) 119M USD -16.7%
Other Assets, Noncurrent 6.25M USD +120%
Assets 928M USD +19.3%
Accounts Payable, Current 10.5M USD +61.1%
Employee-related Liabilities, Current 14.2M USD
Accrued Liabilities, Current 110M USD +50.7%
Liabilities, Current 161M USD +43.5%
Operating Lease, Liability, Noncurrent 863K USD -4.22%
Other Liabilities, Noncurrent 2.21M USD +16.4%
Liabilities 331M USD +11.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 499K USD
Retained Earnings (Accumulated Deficit) -47.3M USD +72.2%
Stockholders' Equity Attributable to Parent 597M USD +24%
Liabilities and Equity 928M USD +19.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 31.1M USD -26.8%
Net Cash Provided by (Used in) Financing Activities -3.63M USD -207%
Net Cash Provided by (Used in) Investing Activities -6.19M USD -246%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 57M shares -2.63%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.3M USD -51.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 388M USD +19.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.59M USD -8.61%
Deferred Tax Assets, Valuation Allowance 5.45M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 150M USD +73.4%
Operating Lease, Liability 2.4M USD -7.31%
Depreciation 163K USD +58.3%
Payments to Acquire Property, Plant, and Equipment 5K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 124M USD -17.8%
Lessee, Operating Lease, Liability, to be Paid 2.55M USD -7.35%
Operating Lease, Liability, Current 1.53M USD -8.97%
Lessee, Operating Lease, Liability, to be Paid, Year Two 597K USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.33M USD -5.19%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +33.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 152K USD -7.88%
Lessee, Operating Lease, Liability, to be Paid, Year Three 91K USD -63.9%
Deferred Tax Assets, Operating Loss Carryforwards 45.9M USD +621%
Operating Lease, Payments 561K USD +31.1%
Amortization of Intangible Assets 23.8M USD -0.01%
Share-based Payment Arrangement, Expense 41.7M USD +39.2%
Interest Expense 4.54M USD -20.9%